Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "6790b39f5037d966855b3484", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Venlafaxine Hydrochloride Extended Release Capsules IP 150mg", "description": "VELAXFINE XR 150 is a trusted pharmaceutical formulation containing Venlafaxine Hydrochloride Extended Release Capsules IP 150mg, designed to manage and alleviate symptoms of major depressive disorders, anxiety, and panic disorders. By maintaining a steady release of the active ingredient, this extended-release formulation provides long-lasting relief, promoting emotional stability and mental well-being throughout the day.\n\n \n\nKey Benefits:\n \nEffective Management of Depression: Helps reduce symptoms such as low mood, fatigue, and loss of interest in daily activities.\nAnxiety and Panic Relief: Alleviates anxiety and panic attacks, promoting calmness and emotional control.\nImproved Sleep Patterns: Supports better sleep quality by reducing symptoms of stress and overthinking.\nLong-Lasting Effect: The extended-release formula ensures steady medication levels for all-day relief.\nEnhanced Emotional Resilience: Boosts energy and concentration, helping patients regain control of their daily lives.\n \n\nHow Does It Work?\n \nVELAXFINE XR 150 functions as a dual-action antidepressant, targeting both serotonin and norepinephrine neurotransmitters. By inhibiting their reuptake in the brain, the medication increases the availability of these mood-regulating chemicals, improving communication between nerve cells. This mechanism helps combat depressive and anxiety symptoms, fostering mental clarity and stability.\n\n \n\nDirections for Use:\n \nDosage: Take one capsule daily or as prescribed by your healthcare provider.\nTiming: Preferably take the capsule at the same time each day to maintain consistent drug levels.\nConsumption: Swallow the capsule whole with water. Do not crush or chew, as this may affect the extended-release mechanism.\nFood: It can be taken with or without food, depending on your doctor's recommendation.\nNote: Always follow the prescribed dosage and consult your healthcare provider for adjustments based on your medical condition.\n\n \n\nSide Effects:\n \nWhile VELAXFINE XR 150 is generally well-tolerated, some individuals may experience:\n\nCommon Side Effects: Nausea, dry mouth, dizziness, drowsiness, or sweating.\nRare Side Effects: Increased heart rate, blurred vision, or difficulty sleeping.\nSevere Reactions: Mood changes, unusual bleeding, or allergic reactions (rash, itching, or swelling).\nIf you experience persistent or severe side effects, seek medical attention promptly.", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "prescribed dosage", "capsule daily", "experience persistent", "unusual bleeding", "generally welltolerated", "velaxfine xr 150", "adjustments based", "healthcare provider", "stability directions", "nerve cells", "medication increases", "norepinephrine neurotransmitters", "reducing symptoms", "sleep quality", "mental wellbeing", "active ingredient", "steady release", "panic disorders", "alleviate symptoms", "daily lives", "food depending", "extendedrelease formulation", "extendedrelease mechanism food", "daily activities anxiety", "trusted pharmaceutical formulation", "doctors recommendation note", "dualaction antidepressant targeting", "overthinking longlasting effect", "low mood fatigue" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2031, "imageuri": "https://productimages.withfloats.com/actual/6790b410ab0e1c3d34a21310.png", "tileimageuri": "https://productimages.withfloats.com/tile/6790b410ab0e1c3d34a21310.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-01-22T09:00:15.61Z", "updatedon": "2025-01-22T09:02:07.236Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/venlafaxine-hydrochloride-extended-release-capsules-ip-150mg/2031", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VELAXFINE XR 150 ", "category": "neurology", "tags": [ "Venlafaxine Prolonged Release Capsules IP 37.5 mg", "is 150 mg of venlafaxine: a high dose", "Venlafaxine hydrochloride extended-release capsules 75 mg", "Is venlafaxine a narcotic", "venlafaxine 150mg modified-release capsules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66696701bd5a4b1cb085393e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CBENZPRIME ER 15 ", "description": "CBENZPRIME ER 15 \nCyclobenzaprine HCl Tablets ER(15mg)\nIntroduction\nCBENZPRIME ER 15 contains Cyclobenzaprine Hydrochloride (15mg) in an extended-release formulation, designed to provide sustained relief from muscle spasms associated with acute, painful musculoskeletal conditions. Cyclobenzaprine is a well-known muscle relaxant that helps alleviate pain and improve mobility by acting on the central nervous system (CNS) to relax muscles.\n\nKey Ingredient and Its Benefits\nCyclobenzaprine HCl (15mg)\nMuscle Relaxant: Cyclobenzaprine effectively relieves muscle spasms by inhibiting nerve impulses that cause pain and muscle contraction.\nExtended-Release Formulation: The extended-release formulation ensures a steady release of the medication over time, providing long-lasting relief from muscle spasms and pain.\nPain Reduction: Cyclobenzaprine helps reduce the discomfort caused by muscle spasms, promoting better mobility and comfort.\nShort-Term Use: Typically prescribed for short-term use in conjunction with rest and physical therapy, Cyclobenzaprine aids in the recovery from acute musculoskeletal conditions.\nBenefits of CBENZPRIME ER 15\nLong-Lasting Relief: The extended-release formulation provides sustained relief from muscle spasms and pain throughout the day.\nEffective Muscle Relaxation: CBENZPRIME ER 15 promotes muscle relaxation, reducing pain and discomfort associated with muscle spasms.\nImproved Mobility: By alleviating muscle spasms, it enhances mobility and range of motion, making it easier to perform daily activities and engage in physical therapy.\nConvenient Dosage: The once-daily dosing of CBENZPRIME ER 15 offers convenience and ensures consistent medication levels in the bloodstream.\nDosage and Administration\nDosage\nMuscle Spasms: The recommended dosage for adults is one extended-release tablet (15mg) taken once daily. The dosage may be adjusted by the healthcare provider based on the patient’s response and tolerability, with a maximum recommended dose of 30mg per day.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as it is designed to release the medication slowly over time.\nConsistency: For optimal results, take CBENZPRIME ER 15 at the same time each day to maintain a consistent level of the medication in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/cbenzprime-er-15-133928", "price": 189.0, "discountamount": 56.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "CNS", "rest", "30mg", "EMAIL", "Order", "water", "range", "motion", "adults", "patient", "muscles", "recovery", "Oral Use", "Benefits", "response", "same time", "discomfort", "full glass", "Consistency", "information", "convenience", "bloodstream", "conjunction", "Introduction", "sterisonline", "sterispharma", "daily dosing", "tolerability", "CALL/WHATSAPP", "muscle spasms", "CBENZPRIME ER", "Short-Term Use", "steady release", "nerve impulses", "Key Ingredient", "Pain Reduction", "optimal results", "muscle relaxant", "sustained relief", "physical therapy", "consistent level", "daily activities", "Convenient Dosage", "Improved Mobility", "muscle contraction", "healthcare provider", "long-lasting relief", "Cyclobenzaprine aids", "Administration Dosage", "central nervous system", "maximum recommended dose", "one extended-release tablet", "Effective Muscle Relaxation", "extended-release formulation", "consistent medication levels", "Cyclobenzaprine Hydrochloride", "Cyclobenzaprine HCl Tablets ER", "acute musculoskeletal conditions", "painful musculoskeletal conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1801, "imageuri": "https://productimages.withfloats.com/actual/666967055e294343790b76bf.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666967055e294343790b76bf.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T09:14:41.453Z", "updatedon": "2024-06-27T06:34:18.57Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cbenzprime-er-15-/1801", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CBENZPRIME ER 15 ", "category": "NEUROLOGY RANGE", "tags": [ "cbenzprime er 15 uses", "cbenzprime er 15 side effects", "cbenzprime er 15 price", "cbenzprime er 15 benefits", "Cyclobenzaprine HCl Tablets ER(15mg)", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66605816dce9381dfcc5822d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BUPROTROP SR 150", "description": "BUPROTROP SR 150\nBupropion HCI ER (150mg)\nBuprotrop SR 150 is a medication containing Bupropion Hydrochloride Extended-Release (ER) in a dosage of 150mg. It belongs to the class of antidepressant medications known as norepinephrine-dopamine reuptake inhibitors (NDRI). Bupropion works by affecting certain chemicals in the brain that play a role in mood regulation.\n\nThis medication is commonly prescribed to treat major depressive disorder (MDD) and seasonal affective disorder (SAD). It may also be used as part of a smoking cessation program to help individuals quit smoking.\n\nThe extended-release formulation of Buprotrop SR 150 ensures a gradual release of the medication in the body, allowing for sustained therapeutic effects over time. It is typically taken once daily, preferably in the morning, with or without food. However, it is essential to follow your healthcare provider's instructions regarding dosage and administration.\n\nAs with any medication, Buprotrop SR 150 may cause side effects such as dry mouth, headache, nausea, insomnia, and changes in appetite. It's important to report any unusual or severe symptoms to your doctor promptly.\n\nBefore starting Buprotrop SR 150, inform your healthcare provider about any medical conditions you have and any other medications or supplements you are taking. Avoid alcohol while taking this medication, as it may increase the risk of seizures.\n\nOverall, Buprotrop SR 150 can be an effective treatment option for depression and smoking cessation when used under medical supervision and in conjunction with other appropriate therapies.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/buprotrop-sr-150-133540\n\n\n\n\n\n\n", "price": 129.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "SAD", "NDRI", "risk", "role", "food", "time", "part", "Call", "body", "class", "150mg", "Email", "brain", "nausea", "doctor", "dosage", "morning", "changes", "alcohol", "unusual", "WhatsApp", "insomnia", "seizures", "appetite", "headache", "chemicals", "dry mouth", "depression", "conjunction", "information", "individuals", "supplements", "instructions", "sterispharma", "buprotrop-sr", "side effects", "sterisonline", "BUPROTROP SR", "administration", "severe symptoms", "gradual release", "mood regulation", "Bupropion HCI ER", "other medications", "medical conditions", "medical supervision", "healthcare provider", "smoking cessation program", "major depressive disorder", "effective treatment option", "antidepressant medications", "other appropriate therapies", "seasonal affective disorder", "extended-release formulation", "sustained therapeutic effects", "Bupropion Hydrochloride Extended-Release", "norepinephrine-dopamine reuptake inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1392, "imageuri": "https://productimages.withfloats.com/actual/6660581a6030c166b1a80e16.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6660581a6030c166b1a80e16.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T12:20:38.186Z", "updatedon": "2024-06-29T11:02:04.936Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/buprotrop-sr-150/1392", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUPROTROP SR 150", "category": "ASTHMARANGE", "tags": [ "BUPROTROP SR 150", "Bupropion HCI ER (150mg)", "What is bupropion SR 150 mg used for", "Bupropion 150 mg side effects", "", "bupropion hydrochloride extended-release", "bupropion er/sr 150 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ed5d67b387b17ecbcba77", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EPSTATE SR 150", "description": "EPSTATE SR 150\nEpalrestat Tablets ER (50mg)\nEPSTATE SR 150 is a medication containing Epalrestat Tablets ER (50mg) as its active ingredient. Epalrestat is an aldose reductase inhibitor used primarily in the management of diabetic neuropathy. The sustained-release formulation ensures a steady release of the medication over an extended period, allowing for convenient once-daily dosing.\n\nDiabetic neuropathy is a common complication of diabetes characterized by nerve damage, often causing pain, tingling, and numbness in the extremities. Epalrestat works by inhibiting aldose reductase, an enzyme involved in the polyol pathway. By blocking this enzyme, Epalrestat helps prevent the accumulation of sorbitol, a sugar alcohol that can build up in nerve cells and contribute to nerve damage.\n\nEPSTATE SR 150 is indicated for the treatment of diabetic neuropathy to alleviate symptoms and potentially slow the progression of nerve damage. By addressing the underlying mechanism of neuropathy, it offers patients relief from pain and discomfort associated with this condition, improving their quality of life.\n\nAs with any medication, EPSTATE SR 150 may cause side effects such as gastrointestinal disturbances, skin reactions, or liver function abnormalities. Patients should be monitored regularly for these adverse effects, and dosage adjustments may be necessary based on individual response and tolerability.\n\nOverall, EPSTATE SR 150 provides an effective treatment option for diabetic neuropathy, offering the convenience of once-daily dosing with its sustained-release formulation. However, it should only be used under the supervision of a healthcare professional and as part of a comprehensive management plan for diabetic neuropathy, which may include lifestyle modifications, blood sugar control, and other therapies aimed at symptom management and preventing further nerve damage.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/epstate-sr-150-133910\n\n\n\n", "price": 189.0, "discountamount": 56.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "pain", "Order", "EMAIL", "relief", "enzyme", "quality", "diabetes", "tingling", "numbness", "patients", "sorbitol", "symptoms", "condition", "discomfort", "convenient", "medication", "EPSTATE SR", "supervision", "information", "nerve cells", "progression", "extremities", "convenience", "accumulation", "sterisonline", "side effects", "tolerability", "nerve damage", "daily dosing", "sterispharma", "sugar alcohol", "CALL/WHATSAPP", "skin reactions", "polyol pathway", "steady release", "extended period", "other therapies", "adverse effects", "active ingredient", "symptom management", "dosage adjustments", "diabetic neuropathy", "individual response", "common complication", "blood sugar control", "underlying mechanism", "Epalrestat Tablets ER", "healthcare professional", "lifestyle modifications", "effective treatment option", "aldose reductase inhibitor", "liver function abnormalities", "gastrointestinal disturbances", "sustained-release formulation", "comprehensive management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1276, "imageuri": "https://productimages.withfloats.com/actual/665ed5d9480b81124f857905.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ed5d9480b81124f857905.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T08:52:38.866Z", "updatedon": "2024-06-04T08:52:38.866Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//epstate-sr-150/1276", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EPSTATE SR 150", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6639c4d7edbab11d945aa483", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EPSTATE SR 150", "description": "EPSTATE SR 150\nEpalrestat Tablets ER (50mg)\nEPSTATE SR 150 features Epalrestat Tablets ER, an extended-release formulation specifically designed to manage and treat diabetic neuropathy. Each tablet contains 150 mg of Epalrestat, which effectively inhibits aldose reductase. This action is crucial in slowing the glucose conversion into sorbitol, a sugar alcohol that, when accumulated, contributes to nerve, eye, and kidney damage associated with diabetes. By managing this pathway, EPSTATE SR 150 helps alleviate symptoms such as pain, numbness, and tingling sensations in the limbs, thus enhancing the quality of life for diabetic patients. This medication is a step forward in preventive diabetic care, focusing on long-term nerve health.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n", "price": 189.0, "discountamount": 57.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "eye", "step", "life", "pain", "limbs", "150 mg", "action", "pathway", "quality", "sorbitol", "diabetes", "numbness", "symptoms", "EPSTATE SR", "medication", "sensations", "sugar alcohol", "kidney damage", "aldose reductase", "diabetic patients", "glucose conversion", "diabetic neuropathy", "Epalrestat Tablets ER", "long-term nerve health", "preventive diabetic care", "extended-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1145, "imageuri": "https://productimages.withfloats.com/actual/6639c4f80070ce584f5b3dc4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6639c4f80070ce584f5b3dc4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-07T06:06:15.321Z", "updatedon": "2024-06-11T12:03:33.198Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/epstate-sr-150/1145", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Epalrestat Tablets ER (50mg)", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6634d5fe3661c211fc3f1714", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CBENZPRIME ER 15 ", "description": "CBENZPRIME ER 15 \nCyclobenzaprine HCl Tablets ER(15mg)\nSTERIMIN ESSENTIAL's CBENZPRIME ER 15 is a potent formulation of Cyclobenzaprine Hydrochloride in extended-release tablets, each containing 15mg of the active ingredient. These tablets are designed for sustained relief from muscle spasms and associated discomfort. CBENZPRIME ER 15 works by targeting the central nervous system, relaxing muscles, and improving mobility. With a focus on quality and efficacy, CBENZPRIME ER 15 from STERIMIN ESSENTIAL is a trusted choice for managing musculoskeletal conditions effectively.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 189.0, "discountamount": 57.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "15mg", "focus", "muscles", "quality", "efficacy", "mobility", "muscle spasms", "CBENZPRIME ER", "trusted choice", "sustained relief", "active ingredient", "STERIMIN ESSENTIAL", "potent formulation", "associated discomfort", "central nervous system", "extended-release tablets", "musculoskeletal conditions", "Cyclobenzaprine Hydrochloride", "Cyclobenzaprine HCl Tablets ER" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1062, "imageuri": "https://productimages.withfloats.com/actual/6634d617043c15118d360b90.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6634d617043c15118d360b90.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-03T12:18:06.253Z", "updatedon": "2024-06-12T11:08:06.88Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cbenzprime-er-15-/1062", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cyclobenzaprine HCl Tablets ER(15mg)", "category": "ORTHOLOGYRANG", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662f6f653d1e541c5802a8da", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LANSOSTRUM 15 JUNIOR ", "description": "LANSOSTRUM 15 JUNIOR \nLansoprazole (15mg)\nLansostrum 15 Junior contains Lansoprazole 15mg, an effective proton pump inhibitor (PPI) used to treat acid-related disorders like gastroesophageal reflux disease (GERD), ulcers, and heartburn. Its mechanism reduces stomach acid production, alleviating symptoms and promoting healing. This formulation is specifically designed for pediatric use, ensuring accurate dosage and safety for children. Common side effects may include headache, nausea, and diarrhea, usually mild and temporary. It's crucial to follow prescribed doses and consult a healthcare professional for proper usage and any concerns.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 75.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PPI", "GERD", "doses", "nausea", "safety", "ulcers", "JUNIOR", "healing", "diarrhea", "headache", "children", "symptoms", "concerns", "heartburn", "mechanism", "LANSOSTRUM", "formulation", "proper usage", "Lansoprazole", "pediatric use", "accurate dosage", "Common side effects", "acid-related disorders", "healthcare professional", "stomach acid production", "gastroesophageal reflux disease", "effective proton pump inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 816, "imageuri": "https://productimages.withfloats.com/actual/662f6f678505c3a3f971cf4a.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f6f678505c3a3f971cf4a.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T09:59:01.404Z", "updatedon": "2024-06-12T12:54:53.775Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lansostrum-15-junior-/816", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Lansoprazole (15mg)", "category": "Pediatric", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68272992e579986392b124bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NINTEPRIDE 150", "description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.", "price": 1050.0, "discountamount": 315.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "nintepride 150", "tumor progression", "capsule swallow", "promoting fibrosis", "nintepride 150nintepride 150", "scheduled dose", "chronic conditions", "lung function", "prescription medication", "ensure safe", "clinical followup", "rash itching", "severe symptoms", "missed skip", "healthcare provider", "schedule prescribed", "time directions", "scar tissue", "growth factors", "lung capacity", "tumor growth", "patients quality", "targeted therapy", "nintedanib 150 mg", "side effects", "gastrointestinal side effects", "orally administered compound", "receptors nintedanib helps", "increased blood pressure", "optimal results follow", "lungs decrease inflammation", "abnormal cell proliferation", "tyrosine kinase inhibitor", "fibrotic diseases helping" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2116, "imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png", "tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-16T12:03:30.781Z", "updatedon": "2025-05-16T12:03:30.781Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintepride-150/2116", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Nintedanib 150mg", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
15 benzydamine formulation?

Still searching for
15 benzydamine formulation?

Chat with us